Pomalidomide

Overview

Pomalidomide is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL43452).

API suppliers (13)

Suppliers of Pomalidomide evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.

• MATRIX PHARMACORP PRIVATE LTDIndia2 active DMF
• OLON SPAItaly1 active DMF GMP on record
• Hetero Labs LimitedIndia1 active DMF GMP on record
• SynthonNetherlands1 active DMF GMP on record
• Natco PharmaIndia1 active DMF GMP on record
• Tianjin Weijie Pharmaceutical Co., Ltd.China1 active DMF
• SHILPA PHARMA LIFESCIENCES LTDIndia1 active DMF
• Cipla USA, Inc.USA1 active DMF
• CHANGZHOU PHARMACEUTICAL FACTORYChina1 active DMF GMP on record
• Deva Holding As1 active DMF GMP on record
• Macleods Pharmaceuticals Ltd.India1 active DMF GMP on record
• WANYANG HENGSHUI PHARMACEUTICAL CO LTDChina1 active DMF
• DR REDDYS LABORATORIES LTD1 active DMF GMP on record

Patent & exclusivity (US)

Per the FDA Orange Book (24 approved US products), the latest listed US patent on Pomalidomide expires 21 Dec 2031 and exclusivity 14 Nov 2027. Generic API sourcing typically opens up once these lapse.

Chemical identity

IUPAC name

4-amino-2-(2,6-dioxopiperidin-3-yl)isoindole-1,3-dione

Canonical SMILES

C1CC(=O)NC(=O)C1N2C(=O)C3=C(C2=O)C(=CC=C3)N

InChIKey

UVSMNLNDYGZFPF-UHFFFAOYSA-N